Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial

Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial

Rationale & Objective: Kidney function progressively declines in most patients with type 2 diabetes (T2DM). Many develop progressive chronic kidney disease (CKD), but some experience a more rapid decline, with a greater risk of kidney failure and cardiovascular disease. In EMPA-REG OUTCOME,...

Full description

Bibliographic Details
Main Authors: Samy Hadjadj, Mark E. Cooper, Dominik Steubl, Michaela Petrini, Stefan Hantel, Michaela Mattheus, Christoph Wanner, Merlin C. Thomas
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Kidney Medicine
Subjects:
Chronic kidney disease
diabetes mellitus
randomized controlled trials
estimated glomerular filtration rate
kidney function
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059523002017

Internet

http://www.sciencedirect.com/science/article/pii/S2590059523002017

Similar Items